Literature DB >> 26448128

Synthesis of Monodisperse Chitosan Nanoparticles and in Situ Drug Loading Using Active Microreactor.

Vivek Kamat1, Ila Marathe1, Vandana Ghormade1, Dhananjay Bodas1, Kishore Paknikar1.   

Abstract

Chitosan nanoparticles are promising drug delivery vehicles. However, the conventional method of unregulated mixing during ionic gelation limits their application because of heterogeneity in size and physicochemical properties. Therefore, a detailed theoretical analysis of conventional and active microreactor models was simulated. This led to design and fabrication of a polydimethylsiloxane microreactor with magnetic micro needles for the synthesis of monodisperse chitosan nanoparticles. Chitosan nanoparticles synthesized conventionally, using 0.5 mg/mL chitosan, were 250 ± 27 nm with +29.8 ± 8 mV charge. Using similar parameters, the microreactor yielded small size particles (154 ± 20 nm) at optimized flow rate of 400 μL/min. Further optimization at 0.4 mg/mL chitosan concentration yielded particles (130 ± 9 nm) with higher charge (+39.8 ± 5 mV). The well-controlled microreactor-based mixing generated highly monodisperse particles with tunable properties including antifungal drug entrapment (80%), release rate, and effective activity (MIC, 1 μg/mL) against Candida.

Entities:  

Keywords:  active microreactor; antifungal activity; chitosan nanoparticles; drug loading; microneedle

Mesh:

Substances:

Year:  2015        PMID: 26448128     DOI: 10.1021/acsami.5b05100

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  2 in total

1.  Molecular simulation and in vitro evaluation of chitosan nanoparticles as drug delivery systems for the controlled release of anticancer drug cytarabine against solid tumours.

Authors:  G Deepa; K C Sivakumar; T P Sajeevan
Journal:  3 Biotech       Date:  2018-11-20       Impact factor: 2.406

2.  Chitosan/tripolyphosphate nanoparticles in active and passive microchannels.

Authors:  Mona Akbari; Zohreh Rahimi; Masoud Rahimi
Journal:  Res Pharm Sci       Date:  2020-12-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.